
Following the news of a “major breakthrough” in genetic research helping to reduce & ‘remove’ the risk of young sudden cardiac death, Dr Steven Cox, CEO of CRY provides the following comment;
Dr Steven Cox – CRY CEO “CRY welcomes the news today of a major investment into research to build on the emerging evidence of gene therapy for some of the conditions which can cause young sudden cardiac death. “In 2008, CRY’s data and analysis showed for the first time that every week in the UK, 12








